|
|
Volumn 359, Issue 9319, 2002, Pages 1709-
|
|
Europe on the brink of direct-to-consumer drug advertising
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
GENERIC DRUG;
OMEPRAZOLE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ASTHMA;
CONSUMER;
DIABETES MELLITUS;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MARKETING;
EDITORIAL;
EUROPE;
FOOD AND DRUG ADMINISTRATION;
GEOGRAPHIC DISTRIBUTION;
HEALTH INSURANCE;
HUMAN;
HYPERTENSION;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
|
|
EID: 0037129713
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08637-3 Document Type: Editorial |
|
Times cited : (16)
|
|
References (0)
|